Robert Bagdorf leads Pfizer’s Search and Evaluation business development group.  This function is responsible for company outreach, asset identification, and due diligence activities across all therapeutic areas for Pfizer’s innovative pharmaceutical business units.  He has 14 years of experience in the identification and evaluation of licensing and acquisition opportunities on both a global and regional basis.  Before assuming his current role, Bob was responsible for opportunity assessment and negotiation of transactions for the Specialty Care Business Unit.

Dr. Bagdorf is a board-certified neurologist who joined Pfizer in 1998 in Neuroscience Clinical Development.  Prior to joining Pfizer, Bob had a large consultative general neurology practice and was the medical director for a community hospital neurodiagnostic center.  He earned a Bachelor’s degree in behavioral biology from Johns Hopkins University, an M.D. from New York University School of Medicine, and a Healthcare MBA from George Washington University. He completed his neurology residency and electrophysiology/epilepsy fellowship at the University of Virginia Medical Center.